Advances in gene therapy for inborn errors of immunity

PURPOSE OF REVIEW: Provide an overview of the landmark accomplishments and state of the art of gene therapy for inborn errors of immunity (IEI). RECENT FINDINGS: Three decades after the first clinical application of gene therapy for IEI, there is one market authorized product available, while for se...

Descripción completa

Detalles Bibliográficos
Autores principales: Ott de Bruin, Lisa M., Lankester, Arjan C., Staal, Frank J.T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
PRIMARY IMMUNE DEFICIENCY DISEASE: Edited by Francesco Cinetto and Virgil Dalm
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621649/
https://www.ncbi.nlm.nih.gov/pubmed/37846903
http://dx.doi.org/10.1097/ACI.0000000000000952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621649/
https://www.ncbi.nlm.nih.gov/pubmed/37846903
http://dx.doi.org/10.1097/ACI.0000000000000952

Ejemplares similares